Irrespective of the underlying mechanism, the selective prognostic impact of BAP1 in ERG negative cancers demonstrate, that the applicability (and perhaps thresholds) of prognostic markers may depend on individual molecular tumor features. This evidence concerns the gene ERG and neoplasm.